166 related articles for article (PubMed ID: 36656864)
1. HER2-driven breast cancer suppression by the JNK signaling pathway.
Itah Z; Chaudhry S; Raju Ponny S; Aydemir O; Lee A; Cavanagh-Kyros J; Tournier C; Muller WJ; Davis RJ
Proc Natl Acad Sci U S A; 2023 Jan; 120(4):e2218373120. PubMed ID: 36656864
[TBL] [Abstract][Full Text] [Related]
2. c-Jun N-terminal kinase activity supports multiple phases of 3D-mammary epithelial acinus formation.
McNally S; McArdle E; Gilligan E; Napoletano S; Gajewska M; Bergin O; McCarthy S; Whyte J; Bianchi A; Stack J; Martin F
Int J Dev Biol; 2011; 55(7-9):731-44. PubMed ID: 22161830
[TBL] [Abstract][Full Text] [Related]
3. MLK3 is critical for breast cancer cell migration and promotes a malignant phenotype in mammary epithelial cells.
Chen J; Miller EM; Gallo KA
Oncogene; 2010 Aug; 29(31):4399-411. PubMed ID: 20514022
[TBL] [Abstract][Full Text] [Related]
4. The cJUN NH
Girnius N; Edwards YJ; Garlick DS; Davis RJ
Elife; 2018 Jun; 7():. PubMed ID: 29856313
[TBL] [Abstract][Full Text] [Related]
5. Roles of human epidermal growth factor receptor 2, c-jun NH2-terminal kinase, phosphoinositide 3-kinase, and p70 S6 kinase pathways in regulation of cyclin G2 expression in human breast cancer cells.
Le XF; Arachchige-Don AS; Mao W; Horne MC; Bast RC
Mol Cancer Ther; 2007 Nov; 6(11):2843-57. PubMed ID: 18025271
[TBL] [Abstract][Full Text] [Related]
6. HER2 drives Mucin-like 1 to control proliferation in breast cancer cells.
Conley SJ; Bosco EE; Tice DA; Hollingsworth RE; Herbst R; Xiao Z
Oncogene; 2016 Aug; 35(32):4225-34. PubMed ID: 26725324
[TBL] [Abstract][Full Text] [Related]
7. CD49f and CD61 identify Her2/neu-induced mammary tumor-initiating cells that are potentially derived from luminal progenitors and maintained by the integrin-TGFβ signaling.
Lo PK; Kanojia D; Liu X; Singh UP; Berger FG; Wang Q; Chen H
Oncogene; 2012 May; 31(21):2614-26. PubMed ID: 21996747
[TBL] [Abstract][Full Text] [Related]
8. Absence of integrin α3β1 promotes the progression of HER2-driven breast cancer in vivo.
Ramovs V; Secades P; Song JY; Thijssen B; Kreft M; Sonnenberg A
Breast Cancer Res; 2019 May; 21(1):63. PubMed ID: 31101121
[TBL] [Abstract][Full Text] [Related]
9. Overexpressed microRNA-136 works as a cancer suppressor in gallbladder cancer through suppression of JNK signaling pathway via inhibition of MAP2K4.
Niu J; Li Z; Li F
Am J Physiol Gastrointest Liver Physiol; 2019 Nov; 317(5):G670-G681. PubMed ID: 31369289
[TBL] [Abstract][Full Text] [Related]
10. MAP2K4 interacts with Vimentin to activate the PI3K/AKT pathway and promotes breast cancer pathogenesis.
Liu S; Huang J; Zhang Y; Liu Y; Zuo S; Li R
Aging (Albany NY); 2019 Nov; 11(22):10697-10710. PubMed ID: 31761784
[TBL] [Abstract][Full Text] [Related]
11. Signaling events mediated by α3β1 integrin are essential for mammary tumorigenesis.
Cagnet S; Faraldo MM; Kreft M; Sonnenberg A; Raymond K; Glukhova MA
Oncogene; 2014 Aug; 33(34):4286-95. PubMed ID: 24077284
[TBL] [Abstract][Full Text] [Related]
12. Black Rice Anthocyanins Suppress Metastasis of Breast Cancer Cells by Targeting RAS/RAF/MAPK Pathway.
Chen XY; Zhou J; Luo LP; Han B; Li F; Chen JY; Zhu YF; Chen W; Yu XP
Biomed Res Int; 2015; 2015():414250. PubMed ID: 26649302
[TBL] [Abstract][Full Text] [Related]
13. Roles of phosphorylated JNK in esophageal squamous cell carcinomas of Kazakh ethnic.
Qin X; Zheng S; Liu T; Liu Q; Liang M; Li X; Sheyhidin I; Lu X
Mol Carcinog; 2014 Jul; 53(7):526-36. PubMed ID: 23359384
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer cells proliferation is regulated by tyrosine phosphatase SHP1 through c-jun N-terminal kinase and cooperative induction of RFX-1 and AP-4 transcription factors.
Amin S; Kumar A; Nilchi L; Wright K; Kozlowski M
Mol Cancer Res; 2011 Aug; 9(8):1112-25. PubMed ID: 21719561
[TBL] [Abstract][Full Text] [Related]
15. AMD-associated genes encoding stress-activated MAPK pathway constituents are identified by interval-based enrichment analysis.
SanGiovanni JP; Lee PH
PLoS One; 2013; 8(8):e71239. PubMed ID: 23940728
[TBL] [Abstract][Full Text] [Related]
16. Sustained c-Jun-NH2-kinase activity promotes epithelial-mesenchymal transition, invasion, and survival of breast cancer cells by regulating extracellular signal-regulated kinase activation.
Wang J; Kuiatse I; Lee AV; Pan J; Giuliano A; Cui X
Mol Cancer Res; 2010 Feb; 8(2):266-77. PubMed ID: 20145041
[TBL] [Abstract][Full Text] [Related]
17. Stress-activated kinase pathway alteration is a frequent event in bladder cancer.
Otto KB; Acharya SS; Robinson VL
Urol Oncol; 2012; 30(4):415-20. PubMed ID: 22154358
[TBL] [Abstract][Full Text] [Related]
18. Jun amino-terminal kinase 1 activation promotes cell survival in ErbB2-positive breast cancer.
Han JS; Crowe DL
Anticancer Res; 2010 Sep; 30(9):3407-12. PubMed ID: 20944115
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Integrin-HER2 signaling by Cucurbitacin B leads to in vitro and in vivo breast tumor growth suppression.
Gupta P; Srivastava SK
Oncotarget; 2014 Apr; 5(7):1812-28. PubMed ID: 24729020
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-22 promotes epithelial cell transformation and breast tumorigenesis via MAP3K8 activation.
Kim K; Kim G; Kim JY; Yun HJ; Lim SC; Choi HS
Carcinogenesis; 2014 Jun; 35(6):1352-61. PubMed ID: 24517997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
